Emergent BioSolutions
EBS
#6912
Rank
NZ$1.00 B
Marketcap
NZ$18.83
Share price
-4.71%
Change (1 day)
-6.78%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): NZ$2.47

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is NZ$2.34. In 2024 the company made an earnings per share (EPS) of NZ-$6.03 an increase over its 2023 EPS that were of NZ-$24.71.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$2.47-141%
2024NZ-$6.03-75.61%
2023NZ-$24.71232.21%
2022NZ-$7.44-203.46%
2021NZ$7.19-25.09%
2020NZ$9.60445.28%
2019NZ$1.76-15.2%
2018NZ$2.08-35.9%
2017NZ$3.2469.57%
2016NZ$1.91-27.67%
2015NZ$2.6465.62%
2014NZ$1.5911.63%
2013NZ$1.4332.31%
2012NZ$1.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.86 21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.61 438.57%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.97 155.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ-$5.38-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.70-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.61-339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.05-55.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel